Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.070094v1, 2006; 10.1373/clinchem.2006.070094
This Article
Right arrow Full Text (PDF)
Right arrow 070094.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.070094v1
52/11/2049    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okazaki, M.
Right arrow Articles by Tomoike, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okazaki, M.
Right arrow Articles by Tomoike, H.

Received on March 12, 2006
Accepted on August 24, 2006

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Component Analysis of HPLC Profiles of Unique Lipoprotein Subclass Cholesterols for Detection of Coronary Artery Disease

Mitsuyo Okazaki 1*, Shinichi Usui 2, Akio Fukui 3, Isao Kubota 3, Hitonobu Tomoike 4

1 Laboratory of Chemistry, College of Liberal Arts and Sciences, Tokyo Medical and Dental University, Ichikawa, Japan
2 Faculty of Health Sciences, Okayama University Medical School, Okayama, Japan
3 Department of Cardiology, Pulmonology and Nephrology, Course of Internal Medicine and Therapeutics, Yamagata University School of Medicine, Yamagata, Japan
4 National Cardiovascular Center, Osaka, Japan

* To whom correspondence should be addressed. E-mail: okazaki.las{at}tmd.ac.jp.

Methods: We performed a simple and fully automated HPLC, followed by mathematical treatment on chromatograms, to measuring cholesterol concentrations of major lipoproteins and their subclasses in 62 male patients (45 with CAD and 17 controls without CAD) who underwent cardiac catheterization.

Results: For major lipoprotein classes, the patient group had a significantly (P <0.05) higher LDL-cholesterol (LDL-C) and lower HDL-cholesterol (HDL-C), but no difference in VLDL-cholesterol (VLDL-C) concentrations. For lipoprotein subclasses, the patient group had a significantly higher small VLDL-C (mean particle diameter of 31.3 nm, P <0.001), small LDL-C (23.0 nm, P <0.05), and very small LDL-C (16.7-20.7 nm, P <0.001), but a significantly lower large HDL-C (12.1 nm, P <0.001) concentrations. Combined variables of "small VLDL-C + small LDL-C + very small LDL-C - large HDL-C" differentiated the patient from the control group more clearly than single-subclass measurements or calculated traditional lipid markers.

Conclusions: These results suggest the usefulness of multiple and simultaneous subclass analysis of proatherogenic and antiatherogenic lipoproteins and indicate that HPLC and its component analysis can be used for easy detection and evaluation of abnormal distribution of lipoprotein subclasses associated with CAD.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Lipid Res.Home page
D. Masuda, K.-i. Hirano, H. Oku, J. C. Sandoval, R. Kawase, M. Yuasa-Kawase, Y. Yamashita, M. Takada, K. Tsubakio-Yamamoto, Y. Tochino, et al.
Chylomicron remnants are increased in the postprandial state in CD36 deficiency
J. Lipid Res., May 1, 2009; 50(5): 999 - 1011.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.